205 related articles for article (PubMed ID: 2008910)
1. Citrate and renal calculi: new insights and future directions.
Pak CY
Am J Kidney Dis; 1991 Apr; 17(4):420-5. PubMed ID: 2008910
[TBL] [Abstract][Full Text] [Related]
2. Citrate and renal calculi: an update.
Pak CY
Miner Electrolyte Metab; 1994; 20(6):371-7. PubMed ID: 7783699
[TBL] [Abstract][Full Text] [Related]
3. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
[TBL] [Abstract][Full Text] [Related]
4. Alkali absorption and citrate excretion in calcium nephrolithiasis.
Sakhaee K; Williams RH; Oh MS; Padalino P; Adams-Huet B; Whitson P; Pak CY
J Bone Miner Res; 1993 Jul; 8(7):789-94. PubMed ID: 8352061
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical action of potassium-magnesium citrate in nephrolithiasis.
Pak CY; Koenig K; Khan R; Haynes S; Padalino P
J Bone Miner Res; 1992 Mar; 7(3):281-5. PubMed ID: 1585829
[TBL] [Abstract][Full Text] [Related]
6. Urine citrate and renal stone disease.
Goldberg H; Grass L; Vogl R; Rapoport A; Oreopoulos DG
CMAJ; 1989 Aug; 141(3):217-21. PubMed ID: 2665909
[TBL] [Abstract][Full Text] [Related]
7. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
[TBL] [Abstract][Full Text] [Related]
8. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment of calcium nephrolithiasis with potassium citrate.
Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F
J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044
[TBL] [Abstract][Full Text] [Related]
10. Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate.
Preminger GM; Sakhaee K; Pak CY
J Urol; 1988 Feb; 139(2):240-2. PubMed ID: 3339718
[TBL] [Abstract][Full Text] [Related]
11. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
Caudarella R; Vescini F
Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
[TBL] [Abstract][Full Text] [Related]
12. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
13. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis.
Ettinger B; Pak CY; Citron JT; Thomas C; Adams-Huet B; Vangessel A
J Urol; 1997 Dec; 158(6):2069-73. PubMed ID: 9366314
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of potassium and magnesium, and citraturic response from potassium-magnesium citrate.
Koenig K; Padalino P; Alexandrides G; Pak CY
J Urol; 1991 Feb; 145(2):330-4. PubMed ID: 1988724
[TBL] [Abstract][Full Text] [Related]
15. Contrasting effects of various potassium salts on renal citrate excretion.
Sakhaee K; Alpern R; Jacobson HR; Pak CY
J Clin Endocrinol Metab; 1991 Feb; 72(2):396-400. PubMed ID: 1899422
[TBL] [Abstract][Full Text] [Related]
16. Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate.
Odvina CV; Mason RP; Pak CY
Am J Ther; 2006; 13(2):101-8. PubMed ID: 16645424
[TBL] [Abstract][Full Text] [Related]
17. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis.
Pak CY; Peterson R; Sakhaee K; Fuller C; Preminger G; Reisch J
Am J Med; 1985 Sep; 79(3):284-8. PubMed ID: 4036979
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate.
Pak CY; Fuller C
Ann Intern Med; 1986 Jan; 104(1):33-7. PubMed ID: 3940503
[TBL] [Abstract][Full Text] [Related]
19. Urinary citrate excretion in patients with renal stone: roles of leucocyte ATP citrate lyase activity and potassium salts therapy.
Tosukhowong P; Borvonpadungkitti S; Prasongwatana V; Tungsanga K; Jutuporn S; Dissayabutr T; Reungjui S; Sriboonlue P
Clin Chim Acta; 2002 Nov; 325(1-2):71-8. PubMed ID: 12367768
[TBL] [Abstract][Full Text] [Related]
20. Effect of varying doses of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss.
Ruml LA; Gonzalez G; Taylor R; Wuermser LA; Pak CY
Am J Ther; 1999 Jan; 6(1):45-50. PubMed ID: 10423646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
